Veeva on technology migration and genAI adoption in life sciences
Last month, Veeva announced multiple generative artificial intelligence (genAI) capabilities in its Vault CRM such as Vault CRM Bot and…
28 Nov 2024
What’s next in prostate cancer detection technologies?
With seven Olympic medals to his name – six of which are gold – Chris Hoy is one of the greatest athletes in British History. But the Scotsman, who was…
21 Nov 2024
Veeva on supporting the data burden in the life sciences sector
As companies in the life sciences sector innovate at a more rapid pace than ever before, all while generating extraordinary volumes of data and navigating various regulatory dictates, data organisation…
20 Nov 2024
Can more investment save the NHS from failing technology?
In the weeks and months since Keir Starmer’s government took the reins in the UK, promises have been made as to how the National Health Service (NHS) will introduce new…
19 Nov 2024
Boosting automation in robotic surgery with AI
With a global physician shortage, populations that are both growing and ageing, and the suggestion that caseloads are continuing to rise, a healthcare crisis is looming. In the past three…
18 Nov 2024
How decentralisation can fill the gaps in Alzheimer’s research
In a new era of Alzheimer’s disease research, the emergence of blockbuster therapies like Eli Lilly’s Kisunla (donanemab) and Eisai and Biogen’s Leqembi (lecanemab) offer renewed hope to patients and…
12 Nov 2024
Are dry powder inhalers the key to sustainable respiratory care?
In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly than…